Allergic reaction are immune responses that occur when the body overreacts to typically harmless substances known as allergens. Upon initial exposure, the immune system sensitizes to the allergen, producing specific antibodies, particularly immunoglobulin E (IgE). Upon subsequent exposure, the allergen binds to IgE on the surface of mast cells and basophils, triggering the release of inflammatory mediators like histamine. Histamine and other chemicals cause the classic symptoms of allergic reactions, including itching, swelling, redness, and, in severe cases, difficulty breathing and anaphylaxis. Allergic reactions can manifest in various forms, affecting the skin (hives, eczema), respiratory system (rhinitis, asthma), gastrointestinal tract, or the entire body. Allergies can develop at any age, and both genetic and environmental factors influence susceptibility. Public awareness, education, and ongoing research are essential for effective prevention, diagnosis, and management of allergic reactions. The severity of allergic reactions varies, ranging from mild discomfort to life-threatening emergencies. Diagnosis involves medical history, physical examination, and sometimes allergen-specific testing. Management includes allergen avoidance, medications such as antihistamines and epinephrine for severe reactions, and immunotherapy for long-term desensitization.
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Post COVID-19 syndrome is associated with sex and severity of first COVID-19 episode in Honduras
Manuel Antonio Sierra Santos, Central American Technological University, Honduras
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Development of a platform UPLC-CAD method for high-throughput lipid quantitation and characterization in novel mRNA LNPs
Janet Muzulu, Sanofi, United States